Brain-derived neurotrophic factor and glucocorticoids: Reciprocal influence on the central nervous system

Neuroscience

Volumn 239, Issue , 2013, Pages 157-172

  Numakawa, T ^a,b   Adachi, N ^a,b   Richards, M ^a,c   Chiba, S ^a,d   Kunugi, H ^a,b  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MUSASHINO UNIVERSITY   (Japan)

Author keywords

BDNF; Glucocorticoids; GR; HPA axis; MR; TrkB

Indexed keywords

ARGIPRESSIN; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CORTICOSTERONE; CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR P75; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE B; STRESS HORMONE;

ANXIETY DISORDER; BDNF GENE; BRAIN DYSFUNCTION; BRAIN REGION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CHRONIC STRESS; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; ENZYME ACTIVATION; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; LONG TERM POTENTIATION; MOLECULAR INTERACTION; NERVE CELL DIFFERENTIATION; NEUROCHEMISTRY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CENTRAL NERVOUS SYSTEM; DEPRESSION; GLUCOCORTICOIDS; HUMANS; NEURONS;

EID: 84876095105     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.09.073     Document Type: Review

References (147)

1. Abidin I., Köhler T., Weiler E., Zoidl G., Eysel U.T., Lessmann V., Mittmann T. Reduced presynaptic efficiency of excitatory synaptic transmission impairs LTP in the visual cortex of BDNF-heterozygous mice. Eur J Neurosci 2006, 24:3519-3531.
2. Adzic M., Djordjevic J., Djordjevic A., Niciforovic A., Demonacos C., Radojcic M., Krstic-Demonacos M. Acute or chronic stress induce cell compartment-specific phosphorylation of glucocorticoid receptor and alter its transcriptional activity in Wistar rat brain. J Endocrinol 2009, 202:87-97.
3. Almeida R.D., Manadas B.J., Melo C.V., Gomes J.R., Mendes C.S., Grãos M.M., Carvalho R.F., Carvalho A.P., Duarte C.B. Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ 2005, 12:1329-1343.
4. Altar C.A., Vawter M.P., Ginsberg S.D. Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology 2009, 34:18-54.
5. Anacker C., Zunszain P.A., Cattaneo A., Carvalho L.A., Garabedian M.J., Thuret S., Price J., Pariante C.M. Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Mol Psychiatry 2011, 16:738-750.
6. Asadi A., Hedman E., Widén C., Zilliacus J., Gustafsson J.A., Wikström A.C. FMS-like tyrosine kinase 3 interacts with the glucocorticoid receptor complex and affects glucocorticoid dependent signaling. Biochem Biophys Res Commun 2008, 368:569-574.
7. Autry A.E., Adachi M., Cheng P., Monteggia L.M. Gender-specific impact of brain-derived neurotrophic factor signaling on stress-induced depression-like behavior. Biol Psychiatry 2009, 66:84-90.
8. Bale T.L., Contarino A., Smith G.W., Chan R., Gold L.H., Sawchenko P.E., Koob G.F., Vale W.W., Lee K.F. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 2000, 24:410-414.
9. Barden N., Stec I.S., Montkowski A., Holsboer F., Reul J.M. Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor. Neuroendocrinology 1997, 66:212-220.
10. Barnabé-Heider F., Miller F.D. Endogenously produced neurotrophins regulate survival and differentiation of cortical progenitors via distinct signaling pathways. J Neurosci 2003, 23:5149-5160.
11. Bartis D., Boldizsár F., Kvell K., Szabó M., Pálinkás L., Németh P., Monostori E., Berki T. Intermolecular relations between the glucocorticoid receptor, ZAP-70 kinase, and Hsp-90. Biochem Biophys Res Commun 2007, 354:253-258.
12. Bartolomucci A., Pederzani T., Sacerdote P., Panerai A.E., Parmigiani S., Palanza P. Behavioral and physiological characterization of male mice under chronic psychosocial stress. Psychoneuroendocrinology 2004, 29:899-910.
13. Bergami M., Rimondini R., Santi S., Blum R., Götz M., Canossa M. Deletion of TrkB in adult progenitors alters newborn neuron integration into hippocampal circuits and increases anxiety-like behavior. Proc Natl Acad Sci U S A 2008, 105:15570-15575.
14. Bergström A., Jayatissa M.N., Mørk A., Wiborg O. Stress sensitivity and resilience in the chronic mild stress rat model of depression; an in situ hybridization study. Brain Res 2008, 1196:41-52.
15. Bibel M., Hoppe E., Barde Y.A. Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR. EMBO J 1999, 18:616-622.
16. Boyle M.P., Brewer J.A., Funatsu M., Wozniak D.F., Tsien J.Z., Izumi Y., Muglia L.J. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc Natl Acad Sci U S A 2005, 102:473-478.
17. Bramham C.R., Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 2005, 76:99-125.
18. Bravo J.A., Díaz-Veliz G., Mora S., Ulloa J.L., Berthoud V.M., Morales P., Arancibia S., Fiedler J.L. Desipramine prevents stress-induced changes in depressive-like behavior and hippocampal markers of neuroprotection. Behav Pharmacol 2009, 20:273-285.
19. Brunet A., Datta S.R., Greenberg M.E. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 2001, 11:297-305.
20. Budziszewska B., Szymanska M., Leskiewicz M., Basta-Kaim A., Jaworska-Feil L., Kubera M., Jantas D., Lason W. The decrease in JNK- and p38-MAP kinase activity is accompanied by the enhancement of PP2A phosphate level in the brain of prenatally stressed rats. J Physiol Pharmacol 2010, 61:207-215.
21. Carroll B.J. The dexamethasone suppression test for melancholia. Br J Psychiatry 1982, 140:292-304.
22. Castrén E., Rantamäki T. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev Neurobiol 2010, 70:289-297.
23. Chao M.V. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 2003, 4:299-309.
24. Chao M.V., Rajagopal R., Lee F.S. Neurotrophin signalling in health and disease. Clin Sci (Lond) 2006, 110:167-173.
25. Chen A., Zorrilla E., Smith S., Rousso D., Levy C., Vaughan J., Donaldson C., Roberts A., Lee K.-F., Vale W. Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior. J Neurosci 2006, 26:5500-5510.
26. Chen G., Kolbeck R., Barde Y.A., Bonhoeffer T., Kossel A. Relative contribution of endogenous neurotrophins in hippocampal long-term potentiation. J Neurosci 1999, 19:7983-7990.
27. Cheung L.W., Leung K.W., Wong C.K., Wong R.N., Wong A.S. Ginsenoside-Rg1 induces angiogenesis via non-genomic crosstalk of glucocorticoid receptor and fibroblast growth factor receptor-1. Cardiovasc Res 2011, 89:419-425.
28. Chiba S., Numakawa T., Ninomiya M., Richards M.C., Wakabayashi C., Kunugi H. Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry 2012, 10.1016/j.pnpbp. 2012.05.018.
29. Chourbaji S., Brandwein C., Gass P. Altering BDNF expression by genetics and/or environment: impact for emotional and depression-like behaviour in laboratory mice. Neurosci Biobehav Rev 2011, 35:599-611.
30. Chourbaji S., Hellweg R., Brandis D., Zörner B., Zacher C., Lang U.E., Henn F.A., Hörtnagl H., Gass P. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Brain Res Mol Brain Res 2004, 121:28-36.
31. Cosgaya J.M., Shooter E.M. Binding of nerve growth factor to its p75 receptor in stressed cells induces selective IkappaB-beta degradation and NF-kappaB nuclear translocation. J Neurochem 2001, 79:391-399.
32. Coyle J.T., Duman R.S. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 2003, 38:157-160.
33. Duman R.S., Malberg J., Nakagawa S., D'Sa C. Neuronal plasticity and survival in mood disorders. Biol Psychiatry 2000, 48:732-739.
34. Dwivedi Y., Rizavi H.S., Roberts R.C., Conley R.C., Tamminga C.A., Pandey G.N. Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 2001, 77:916-928.
35. Easton J.B., Royer A.R., Middlemas D.S. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor. J Neurochem 2006, 97:834-845.
36. Ernfors P., Hallböök F., Ebendal T., Shooter E.M., Radeke M.J., Misko T.P., Persson H. Developmental and regional expression of beta-nerve growth factor receptor mRNA in the chick and rat. Neuron 1988, 1:983-996.
37. Esposito D., Patel P., Stephens R.M., Perez P., Chao M.V., Kaplan D.R., Hempstead B.L. The cytoplasmic and transmembrane domains of the p75 and Trk A receptors regulate high affinity binding to nerve growth factor. J Biol Chem 2001, 276:32687-32695.
38. Figurov A., Pozzo-Miller L.D., Olafsson P., Wang T., Lu B. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 1996, 381:706-709.
39. Friedman W.J., Olson L., Persson H. Temporal and spatial expression of NGF receptor mRNA during postnatal rat brain development analyzed by in situ hybridization. Brain Res Dev Brain Res 1991, 63:43-51.
40. Finkbeiner S., Tavazoie S.F., Maloratsky A., Jacobs K.M., Harris K.M., Greenberg M.E. CREB: a major mediator of neuronal neurotrophin responses. Neuron 1997, 19:1031-1047.
41. Furay A.R., Bruestle A.E., Herman J.P. The role of the forebrain glucocorticoid receptor in acute and chronic stress. Endocrinology 2008, 149:5482-5490.
42. Gass P., Henn F.A. Is there a role for neurogenesis in depression?. Biol Psychiatry 2009, 66:3-4.
43. Gass P., Reichardt H.M., Strekalova T., Henn F., Tronche F. Mice with targeted mutations of glucocorticoid and mineralocorticoid receptors: models for depression and anxiety?. Physiol Behav 2001, 73:811-825.
44. Givalois L., Naert G., Rage F., Ixart G., Arancibia S., Tapia-Arancibia L. A single brain-derived neurotrophic factor injection modifies hypothalamo-pituitary-adrenocortical axis activity in adult male rats. Mol Cell Neurosci 2004, 27:280-295.
45. Gottmann K., Mittmann T., Lessmann V. BDNF signaling in the formation, maturation and plasticity of glutamatergic and GABAergic synapses. Exp Brain Res 2009, 199:203-234.
46. Groeneweg F.L., Karst H., de Kloet E.R., Joëls M. Mineralocorticoid and glucocorticoid receptors at the neuronal membrane, regulators of nongenomic corticosteroid signalling. Mol Cell Endocrinol 2012, 350:299-309.
47. Grossmann C., Wuttke M., Ruhs S., Seiferth A., Mildenberger S., Rabe S., Schwerdt G., Gekle M. Mineralocorticoid receptor inhibits CREB signaling by calcineurin activation. FASEB J 2010, 24:2010-2019.
48. Hale C.F., Dietz K.C., Varela J.A., Wood C.B., Zirlin B.C., Leverich L.S., Greene R.W., Cowan C.W. Essential role for vav Guanine nucleotide exchange factors in brain-derived neurotrophic factor-induced dendritic spine growth and synapse plasticity. J Neurosci 2011, 31:12426-12436.
49. Han B.H., Holtzman D.M. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 2000, 20:5775-5781.
50. Hanafusa H., Torii S., Yasunaga T., Matsumoto K., Nishida E. Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor Sprouty. J Biol Chem 2004, 279:22992-22995.
51. Hanson N.D., Owens M.J., Nemeroff C.B. Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology 2011, 36:2589-2602.
52. Harrington A.W., Kim J.Y., Yoon S.O. Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. J Neurosci 2002, 22:156-166.
53. Hatzinger M., Reul J.M., Landgraf R., Holsboer F., Neumann I. Combined dexamethasone/CRH test in rats: hypothalamo-pituitary-adrenocortical system alterations in aging. Neuroendocrinology 1996, 64:349-356.
54. He X.L., Garcia K.C. Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science 2004, 304:870-875.
55. Hetman M., Cavanaugh J.E., Kimelman D., Xia Z. Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J Neurosci 2000, 20:2567-2574.
56. Heuser I., Yassouridis A., Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J Psychiatr Res 1994, 28:341-356.
57. Holsboer F., von Bardeleben U., Wiedemann K., Müller O.A., Stalla G.K. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression. Biol Psychiatry 1987, 22:228-234.
58. Hu X., Ballo L., Pietila L., Viesselmann C., Ballweg J., Lumbard D., Stevenson M., Merriam E., Dent E.W. BDNF-induced increase of PSD-95 in dendritic spines requires dynamic microtubule invasions. J Neurosci 2011, 31:15597-15603.
59. Huang E.J., Reichardt L.F. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 2003, 72:609-642.
60. Ibáñez C.F., Ebendal T., Barbany G., Murray-Rust J., Blundell T.L., Persson H. Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell 1992, 69:329-341.
61. Ibáñez C.F., Simi A. P75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity. Trends Neurosci 2012, 35:431-440.
62. Ising M., Künzel H.E., Binder E.B., Nickel T., Modell S., Holsboer F. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1085-1093.
63. Jafari M., Seese R.R., Babayan A.H., Gall C.M., Lauterborn J.C. Glucocorticoid receptors are localized to dendritic spines and influence local actin signaling. Mol Neurobiol 2012, 46:304-315.
64. Jeanneteau F., Garabedian M.J., Chao M.V. Activation of Trk neurotrophin receptors by glucocorticoids provides a neuroprotective effect. Proc Natl Acad Sci U S A 2008, 105:4862-4867.
65. Jeanneteau F.D., Lambert W.M., Ismaili N., Bath K.G., Lee F.S., Garabedian M.J., Chao M.V. BDNF and glucocorticoids regulate corticotrophin-releasing hormone (CRH) homeostasis in the hypothalamus. Proc Natl Acad Sci U S A 2012, 109:1305-1310.
66. Jiang B., Xiong Z., Yang J., Wang W., Wang Y., Hu Z.L., Wang F., Chen J.G. Antidepressant-like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus. Br J Pharmacol 2012, 166:1872-1887.
67. Kang H., Welcher A.A., Shelton D., Schuman E.M. Neurotrophins and time: different roles for TrkB signaling in hippocampal long-term potentiation. Neuron 1997, 19:653-664.
68. Kaplan D.R., Miller F.D. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 2000, 10:381-391.
69. Karst H., Berger S., Erdmann G., Schütz G., Joëls M. Metaplasticity of amygdalar responses to the stress hormone corticosterone. Proc Natl Acad Sci U S A 2010, 107:14449-14454.
70. Karst H., Berger S., Turiault M., Tronche F., Schütz G., Joëls M. Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci U S A 2005, 102:19204-19207.
71. Keck M.E., Welt T., Müller M.B., Uhr M., Ohl F., Wigger A., Toschi N., Holsboer F., Landgraf R. Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology 2003, 28:235-243.
72. Keck M.E., Wigger A., Welt T., Müller M.B., Gesing A., Reul J.M.H.M., Holsboer F., Landgraf R., Neumann I.D. Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders. Neuropsychopharmacology 2002, 26:94-105.
73. Kikusui T., Ichikawa S., Mori Y. Maternal deprivation by early weaning increases corticosterone and decreases hippocampal BDNF and neurogenesis in mice. Psychoneuroendocrinology 2009, 34:762-772.
74. Kim E.K., Choi E.J. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 2010, 1802:396-405.
75. Kim J.B., Ju J.Y., Kim J.H., Kim T.Y., Yang B.H., Lee Y.S., Son H. Dexamethasone inhibits proliferation of adult hippocampal neurogenesis in vivo and in vitro. Brain Res 2004, 1027:1-10.
76. Kino T., Jaffe H., Amin N.D., Chakrabarti M., Zheng Y.L., Chrousos G.P., Pant H.C. Cyclin-dependent kinase 5 modulates the transcriptional activity of the mineralocorticoid receptor and regulates expression of brain-derived neurotrophic factor. Mol Endocrinol 2010, 24:941-952.
77. Kishimoto T., Radulovic J., Radulovic M., Lin C.R., Schrick C., Hooshmand F., Hermanson O., Rosenfeld M.G., Spiess J. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet 2000, 24:415-419.
78. Komatsuzaki Y., Hatanaka Y., Murakami G., Mukai H., Hojo Y., Saito M., Kimoto T., Kawato S. Corticosterone induces rapid spinogenesis via synaptic glucocorticoid receptors and kinase networks in hippocampus. PLoS One 2012, 7:e34124.
79. Korte M., Minichiello L., Klein R., Bonhoeffer T. Shc-binding site in the TrkB receptor is not required for hippocampal long-term potentiation. Neuropharmacology 2000, 39:717-724.
80. Kossel A.H., Cambridge S.B., Wagner U., Bonhoeffer T. A caged Ab reveals an immediate/instructive effect of BDNF during hippocampal synaptic potentiation. Proc Natl Acad Sci U S A 2001, 98:14702-14707.
81. Kronenberg G., Kirste I., Inta D., Chourbaji S., Heuser I., Endres M., Gass P. Reduced hippocampal neurogenesis in the GR(+/-) genetic mouse model of depression. Eur Arch Psychiatry Clin Neurosci 2009, 259:499-504.
82. Kumamaru E., Numakawa T., Adachi N., Kunugi H. Glucocorticoid suppresses BDNF-stimulated MAPK/ERK pathway via inhibiting interaction of Shp2 with TrkB. FEBS Lett 2011, 585:3224-3228.
83. Kumar V., Zhang M.X., Swank M.W., Kunz J., Wu G.Y. Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J Neurosci 2005, 25:11288-11299.
84. Kuroda Y., McEwen B.S. Effect of chronic restraint stress and tianeptine on growth factors, growth-associated protein-43 and microtubule-associated protein 2 mRNA expression in the rat hippocampus. Brain Res Mol Brain Res 1998, 59:35-39.
85. Lee R., Kermani P., Teng K.K., Hempstead B.L. Regulation of cell survival by secreted proneurotrophins. Science 2001, 294:1945-1948.
86. Li Y., Luikart B.W., Birnbaum S., Chen J., Kwon C.H., Kernie S.G., Bassel-Duby R., Parada L.F. TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 2008, 59:399-412.
87. Lyons W.E., Mamounas L.A., Ricaurte G.A., Coppola V., Reid S.W., Bora S.H., Wihler C., Koliatsos V.E., Tessarollo L. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A 1999, 96:15239-15244.
88. Meng B., Zhang Q., Huang C., Zhang H.T., Tang T., Yang H.L. Effects of a single dose of methylprednisolone versus three doses of rosiglitazone on nerve growth factor levels after spinal cord injury. J Int Med Res 2011, 39:805-814.
89. Minichiello L. TrkB signalling pathways in LTP and learning. Nat Rev Neurosci 2009, 10:850-860.
90. Minichiello L., Calella A.M., Medina D.L., Bonhoeffer T., Klein R., Korte M. Mechanism of TrkB-mediated hippocampal long-term potentiation. Neuron 2002, 36:121-137.
91. Mizoguchi K., Shoji H., Ikeda R., Tanaka Y., Tabira T. Persistent depressive state after chronic stress in rats is accompanied by HPA axis dysregulation and reduced prefrontal dopaminergic neurotransmission. Pharmacol Biochem Behav 2008, 91:170-175.
92. Mizoguchi K., Yuzurihara M., Ishige A., Sasaki H., Chui D.H., Tabira T. Chronic stress differentially regulates glucocorticoid negative feedback response in rats. Psychoneuroendocrinology 2001, 26:443-459.
93. Molteni R., Calabrese F., Chourbaji S., Brandwein C., Racagni G., Gass P., Riva M.A. Depression-prone mice with reduced glucocorticoid receptor expression display an altered stress-dependent regulation of brain-derived neurotrophic factor and activity-regulated cytoskeleton-associated protein. J Psychopharmacol 2010, 24:595-603.
94. Mowla S.J., Farhadi H.F., Pareek S., Atwal J.K., Morris S.J., Seidah N.G., Murphy R.A. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J Biol Chem 2001, 276:12660-12666.
95. Naert G., Ixart G., Maurice T., Tapia-Arancibia L., Givalois L. Brain-derived neurotrophic factor and hypothalamic-pituitary-adrenal axis adaptation processes in a depressive-like state induced by chronic restraint stress. Mol Cell Neurosci 2011, 46:55-66.
96. Nair A., Vaidya V.A. Cyclic AMP response element binding protein and brain-derived neurotrophic factor: molecules that modulate our mood?. J Biosci 2006, 31:423-434.
97. Nollet M., Gaillard P., Tanti A., Girault V., Belzung C., Leman S. Neurogenesis-independent antidepressant-like effects on behavior and stress axis response of a dual orexin receptor antagonist in a rodent model of depression. Neuropsychopharmacology 2012, 10.1038/npp. 2012.70.
98. Numakawa T, Adachi N, Richards M, Chiba S, Kunugi H (2012) The influence of glucocorticoids on neuronal survival and synaptic function. Biomol Concepts, in press.
99. Numakawa T., Kumamaru E., Adachi N., Yagasaki Y., Izumi A., Kunugi H. Glucocorticoid receptor interaction with TrkB promotes BDNF-triggered PLC-gamma signaling for glutamate release via a glutamate transporter. Proc Natl Acad Sci U S A 2009, 106:647-652.
100. Nykjaer A., Lee R., Teng K.K., Jansen P., Madsen P., Nielsen M.S., Jacobsen C., Kliemannel M., Schwarz E., Willnow T.E., Hempstead B.L., Petersen C.M. Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004, 427:843-848.
101. Ohira K., Hayashi M. A new aspect of the TrkB signaling pathway in neural plasticity. Curr Neuropharmacol 2009, 7:276-285.
102. Ohnishi H., Murata T., Kusakari S., Hayashi Y., Takao K., Maruyama T., Ago Y., Koda K., Jin F.J., Okawa K., Oldenborg P.A., Okazawa H., Murata Y., Furuya N., Matsuda T., Miyakawa T., Matozaki T. Stress-evoked tyrosine phosphorylation of signal regulatory protein α regulates behavioral immobility in the forced swim test. J Neurosci 2010, 30:10472-10483.
103. Ohnishi H., Murata Y., Okazawa H., Matozaki T. Src family kinases: modulators of neurotransmitter receptor function and behavior. Trends Neurosci 2011, 34:629-637.
104. Pang P.T., Teng H.K., Zaitsev E., Woo N.T., Sakata K., Zhen S., Teng K.K., Yung W.H., Hempstead B.L., Lu B. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 2004, 306:487-491.
105. Pasricha N., Joëls M., Karst H. Rapid effects of corticosterone in the mouse dentate gyrus via a nongenomic pathway. J Neuroendocrinol 2011, 23:143-147.
106. Pozzo-Miller L.D., Gottschalk W., Zhang L., McDermott K., Du J., Gopalakrishnan R., Oho C., Sheng Z.H., Lu B. Impairments in high-frequency transmission, synaptic vesicle docking, and synaptic protein distribution in the hippocampus of BDNF knockout mice. J Neurosci 1999, 19:4972-4983.
107. Reagan L.P., Hendry R.M., Reznikov L.R., Piroli G.G., Wood G.E., McEwen B.S., Grillo C.A. Tianeptine increases brain-derived neurotrophic factor expression in the rat amygdala. Eur J Pharmacol 2007, 565:68-75.
108. Ridder S., Chourbaji S., Hellweg R., Urani A., Zacher C., Schmid W., Zink M., Hörtnagl H., Flor H., Henn F.A., Schütz G., Gass P. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J Neurosci 2005, 25:6243-6250.
109. Rios M., Fan G., Fekete C., Kelly J., Bates B., Kuehn R., Lechan R.M., Jaenisch R. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 2001, 15:1748-1757.
110. Rocher C., Spedding M., Munoz C., Jay T.M. Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants. Cereb Cortex 2004, 14:224-229.
111. Sakata K., Jin L., Jha S. Lack of promoter IV-driven BDNF transcription results in depression-like behavior. Genes Brain Behav 2010, 9:712-721.
112. Sampaio C., Dance M., Montagner A., Edouard T., Malet N., Perret B., Yart A., Salles J.P., Raynal P. Signal strength dictates phosphoinositide 3-kinase contribution to Ras/extracellular signal-regulated kinase 1 and 2 activation via differential Gab1/Shp2 recruitment: consequences for resistance to epidermal growth factor receptor inhibition. Mol Cell Biol 2008, 28:587-600.
113. Samuels B.A., Hen R. Neurogenesis and affective disorders. Eur J Neurosci 2011, 33:1152-1159.
114. Samarasinghe R.A., Di Maio R., Volonte D., Galbiati F., Lewis M., Romero G., DeFranco D.B. Nongenomic glucocorticoid receptor action regulates gap junction intercellular communication and neural progenitor cell proliferation. Proc Natl Acad Sci U S A 2011, 108:16657-16662.
115. Santos A.R., Comprido D., Duarte C.B. Regulation of local translation at the synapse by BDNF. Prog Neurobiol 2010, 92:505-516.
116. Schinder A.F., Poo M. The neurotrophin hypothesis for synaptic plasticity. Trends Neurosci 2000, 23:639-645.
117. Schnydrig S., Korner L., Landweer S., Ernst B., Walker G., Otten U., Kunz D. Peripheral lipopolysaccharide administration transiently affects expression of brain-derived neurotrophic factor, corticotropin and proopiomelanocortin in mouse brain. Neurosci Lett 2007, 429:69-73.
118. Schulte-Herbrüggen O., Chourbaji S., Ridder S., Brandwein C., Gass P., Hörtnagl H., Hellweg R. Stress-resistant mice overexpressing glucocorticoid receptors display enhanced BDNF in the amygdala and hippocampus with unchanged NGF and serotonergic function. Psychoneuroendocrinology 2006, 31:1266-1277.
119. Schulte-Herbrüggen O., Hellweg R., Chourbaji S., Ridder S., Brandwein C., Gass P., Hörtnagl H. Differential regulation of neurotrophins and serotonergic function in mice with genetically reduced glucocorticoid receptor expression. Exp Neurol 2007, 204:307-316.
120. Seiferth A., Ruhs S., Mildenberger S., Gekle M., Grossmann C. The phosphatase calcineurin PP2BAβ mediates part of mineralocorticoid receptor transcriptional activity. FASEB J 2012, 26:2327-2337.
121. Shiflett M.W., Balleine B.W. Contributions of ERK signaling in the striatum to instrumental learning and performance. Behav Brain Res 2011, 218:240-247.
122. Smith G.W., Aubry J.M., Dellu F., Contarino A., Bilezikjian L.M., Gold L.H., Chen R., Marchuk Y., Hauser C., Bentley C.A., Sawchenko P.E., Koob G.F., Vale W., Lee K.F. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 1998, 20:1093-1102.
123. Sohrabji F., Lewis D.K. Estrogen-BDNF interactions: implications for neurodegenerative diseases. Front Neuroendocrinol 2006, 27:404-414.
124. Steimer T., Python A., Schulz P.E., Aubry J.-M. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression. Psychoneuroendocrinology 2007, 32:575-579.
125. Stenzel-Poore M.P., Heinrichs S.C., Rivest S., Koob G.F., Vale W.W. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neurosci 1994, 14:2579-2584.
126. Stranahan A.M. Physiological variability in brain-derived neurotrophic factor expression predicts dendritic spine density in the mouse dentate gyrus. Neurosci Lett 2011, 495:60-62.
127. Sweatt J.D. Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 2004, 14:311-317.
128. Takuma K., Matsuo A., Himeno Y., Hoshina Y., Ohno Y., Funatsu Y., Arai S., Kamei H., Mizoguchi H., Nagai T., Koike K., Inoue M., Yamada K. 17Beta-estradiol attenuates hippocampal neuronal loss and cognitive dysfunction induced by chronic restraint stress in ovariectomized rats. Neuroscience 2007, 146:60-68.
129. Teng H.K., Teng K.K., Lee R., Wright S., Tevar S., Almeida R.D., Kermani P., Torkin R., Chen Z.Y., Lee F.S., Kraemer R.T., Nykjaer A., Hempstead B.L. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J Neurosci 2005, 25:5455-5463.
130. Teng K.K., Felice S., Kim T., Hempstead B.L. Understanding proneurotrophin actions: recent advances and challenges. Dev Neurobiol 2010, 70:350-359.
131. Toriya M., Maekawa F., Maejima Y., Onaka T., Fujiwara K., Nakagawa T., Nakata M., Yada T. Long-term infusion of brain-derived neurotrophic factor reduces food intake and body weight via a corticotrophin-releasing hormone pathway in the paraventricular nucleus of the hypothalamus. J Neuroendocrinol 2010, 22:987-995.
132. Tronche F., Kellendonk C., Kretz O., Gass P., Anlag K., Orban P.C., Bock R., Klein R., Schütz G. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 1999, 23:99-103.
133. Verpelli C., Piccoli G., Zanchi A., Gardoni F., Huang K., Brambilla D., Di Luca M., Battaglioli E., Sala C. Synaptic activity controls dendritic spine morphology by modulating eEF2-dependent BDNF synthesis. J Neurosci 2010, 30:5830-5842.
134. Vetter D.E., Li C., Zhao L., Contarino A., Liberman M.C., Smith G.W., Marchuk Y., Koob G.F., Heinemann S.F., Vale W., Lee K.-F. Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior. Nat Genet 2002, 31:363-369.
135. Wang X., Su H., Copenhagen L.D., Vaishnav S., Pieri F., Shope C.D., Brownell W.E., Biasi M.D., Paylor R., Bradley A. Urocortin-deficient mice display normal stress-induced anxiety behavior and autonomic control but an impaired acoustic startle response. Mol Cell Biol 2002, 22:6605-6610.
136. Wang Y., Gu J., Wang J., Feng X., Tao Y., Jiang B., He J., Wang Q., Yang J., Zhang S., Cai J., Sun Y. BDNF and NT-3 expression by using glucocorticoid-induced bicistronic expression vector pGC-BDNF-IRES-NT3 protects apoptotic cells in a cellular injury model. Brain Res 2012, 1448:137-143.
137. Wehrman T., He X., Raab B., Dukipatti A., Blau H., Garcia K.C. Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors. Neuron 2007, 53:25-38.
138. Weninger S.C., Dunn A.J., Muglia L.J., Dikkes P., Miczek K.A., Swiergiel A.H., Berridge C.W., Majzoub J.A. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proc Natl Acad Sci U S A 1999, 96:8283-8288.
139. Wersinger S.R., Ginns E.I., O'Carroll A.-M., Lolait S.J., Young W.S. Vasopressin V1b receptor knockout reduces aggressive behavior in male mice. Mol Psychiatry 2002, 7:975-984.
140. Wyatt S., Shooter E.M., Davies A.M. Expression of the NGF receptor gene in sensory neurons and their cutaneous targets prior to and during innervation. Neuron 1990, 4:421-427.
141. Xu H., Chen Z., He J., Haimanot S., Li X., Dyck L., Li X.-M. Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus 2006, 16:551-559.
142. Yan W., Zhang T., Jia W., Sun X., Liu X. Chronic stress impairs learning and hippocampal cell proliferation in senescence-accelerated prone mice. Neurosci Lett 2011, 490:85-89.
143. Ying S.W., Futter M., Rosenblum K., Webber M.J., Hunt S.P., Bliss T.V., Bramham C.R. Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J Neurosci 2002, 22:1532-1540.
144. Yoshii A., Constantine-Paton M. BDNF induces transport of PSD-95 to dendrites through PI3K-AKT signaling after NMDA receptor activation. Nat Neurosci 2007, 10:702-711.
145. Yoshii A., Constantine-Paton M. Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev Neurobiol 2010, 70:304-322.
146. Yu H., Chen Z.Y. The role of BDNF in depression on the basis of its location in the neural circuitry. Acta Pharmacol Sin 2011, 32:3-11.
147. Zörner B., Wolfer D.P., Brandis D., Kretz O., Zacher C., Madani R., Grunwald I., Lipp H.P., Klein R., Henn F.A., Gass P. Forebrain-specific TrkB-receptor knockout mice: behaviorally more hyperactive than " depressive" Biol Psychiatry 2003, 54:972-982.